Table 1.
Demographic and Clinical Data
| Variables | Patients (20) | Controls (20) | Statistics | ||
|---|---|---|---|---|---|
| Tests | df | P | |||
| Sex (m/f) | (12/8) | (13/7) | X 2 = 0.1 | 2 | .744 |
| Age (y) | 34.3 (12.6) | 30.5 (11.5) | T = –1.0 | 38 | .324 |
| Education (y) | 12.2 (2.6) | 14.8 (2.1) | T = 3.6 | 38 | .001 |
| DSB | 9.2 (5.7) | 15.1 (5.6) | T = 3.3 | 38 | .002 |
| FAB | 15.2 (1.7) | 15.5 (1.2) | T = 0.6 | 38 | .536 |
| CPZ (mg) | 478.9 (638.1) | ||||
| DOI (y) | 11.6 (8.9) | ||||
| PANSS positive | 21.7 (10.5) | ||||
| PANSS negative | 28.4 (7.4) | ||||
| PANSS total | 96.6 (24.2) |
Note: CPZ, chlorpromazine equivalents; DOI, duration of illness; PANSS, Positive and Negative Syndrome Scale; DSB, digit span backward; FAB, frontal assessment battery. Significant values highlighted in bold.